Dominik Naczynski

Dominik Naczynski is a senior executive at Boxer Capital, LLC, a family office focused on public and private investments in healthcare. While some sources refer to him as a Managing Director, his most current title appears to be Senior Vice President.1

Professional Background

Dr. Naczynski joined Boxer Capital in 2014 and is responsible for conducting due diligence on public and private investments in the healthcare sector.1 In addition to his role at Boxer Capital, he serves as a Member of the Board of Directors for Cedilla Therapeutics, Inc.1

Education and Research

Dr. Naczynski has an impressive educational background:

• Ph.D. in Chemical Engineering from Rutgers University (NIH-sponsored Biotechnology Fellow)
• Bachelor of Arts degree in Chemical Engineering from Cornell University
• Postdoctoral training in radiation oncology at Stanford University School of Medicine
• Graduate of the Ignite Program at Stanford Graduate School of Business1

His research accomplishments include:

• Authoring publications in leading scientific journals, including Nature Communications
• Co-inventor on several medical device patents
• Recipient of research grants from organizations such as the National Institutes of Health, National Cancer Institute, and Department of Defense1

Current Responsibilities

As Senior Vice President at Boxer Capital, Dr. Naczynski's primary responsibilities include:

• Conducting due diligence on healthcare investments
• Evaluating both public and private investment opportunities in the healthcare sector
• Contributing to the strategic direction of the company's investment portfolio1

Dr. Naczynski's expertise in biotechnology and chemical engineering, combined with his extensive research background, positions him as a valuable asset in Boxer Capital's healthcare investment strategy.